Pushkal Garg - EVP Chief R&D at ALNYLAM PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP Chief R&D
Issuer Symbol
ALNY on Nasdaq
All Insider Reports
All Insider Reports

Pushkal Garg - trading volume in the past year for ALNYLAM PHARMACEUTICALS, INC.

Holdings reported by Pushkal Garg for ALNYLAM PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 18,693 $6,095,413 $326.08 05 Mar 2026 Direct
Restricted Stock Units 0 $465,762 $244.11 27 Feb 2026 Direct Common Stock
Common Stock 431 $138,902 $322.28 04 Mar 2026 by Managed Account
Common Stock 250 $80,570 $322.28 04 Mar 2026 by Trust
Stock Option (right to buy) 10,480 02 Mar 2026 Direct Common Stock

Transactions reported by Pushkal Garg for ALNYLAM PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.